Veeva (VEEV) Reports Fiscal 2026 Third Quarter Earnings Results

Veeva Systems Inc. (VEEV) today announced its financial results for the most recent quarter, revealing a mixed performance. The company reported quarterly revenue of $811.2 million, surpassing analysts’ expectations by approximately $18.4 million, while earnings per share came in at $1.40, falling short of the estimated $1.95. This earnings miss highlights the challenges Veeva faced during the quarter, despite a strong revenue performance.

Key Highlights:

• Total revenues for Q3 FY2026 reached $811.2 million, a 16% increase year-over-year.
• Subscription services revenues were $682.5 million, up 17% from the previous year.
• Operating income increased by 33% to $240.9 million, while non-GAAP operating income rose 20% to $364.9 million.
• Net income for the quarter was $236.2 million, a 27% increase year-over-year.
• CEO Peter Gassner emphasized the rapid advancement of Veeva AI, stating it will enhance productivity and customer centricity in the life sciences industry.
• CFO Brian Van Wagener noted broad-based strength across the business and increased full-year guidance, aiming for a $6 billion revenue run-rate by 2030.
• Veeva AI is set to release its first agents for CRM and commercial content in December, with further developments planned for 2026.
• Veeva Development Cloud is gaining traction, with three top 20 biopharma companies selecting its applications as enterprise standards.

Veeva Systems reported strong financial results for the third quarter of fiscal 2026, with total revenues of $811.2 million, marking a 16% increase compared to the same period last year. Subscription services revenues also saw significant growth, rising 17% to $682.5 million. The company’s operating income surged by 33% to $240.9 million, and net income increased by 27% to $236.2 million. CEO Peter Gassner highlighted the importance of Veeva AI in driving innovation within the life sciences sector, stating, “Veeva AI delivers on our vision for industry-specific AI that will help the life sciences industry reach new levels of productivity and customer centricity.”

Looking ahead, CFO Brian Van Wagener expressed confidence in the company’s trajectory, stating, “Our third quarter results and increased full-year guidance demonstrate the broad-based strength we see across the business.” Veeva is on track to achieve a $6 billion revenue run-rate goal by 2030, with ongoing advancements in Veeva AI and the Veeva Development Cloud, which is being adopted by major biopharma companies. The company has provided guidance for the upcoming fiscal fourth quarter, projecting total revenues between $807 and $810 million.

Veeva Systems Inc. (VEEV) has experienced a notable fluctuation in its stock price, with a sharp decline of 8.07% over the past week, reflecting investor concerns despite its strong fundamentals. Over the last month, the stock has dipped by 3.78%, and a slight 3.99% decrease over the past three months suggests a period of consolidation. However, the longer-term outlook remains positive, as evidenced by a robust 30.07% increase over the past year and a commendable 13.92% rise in the last six months. The company’s financial metrics paint a promising picture, with a price-to-earnings ratio of 55.80 indicating strong growth expectations, supported by an impressive 21.12% compound annual growth rate (CAGR) in earnings per share over the last two years. Additionally, Veeva’s revenue CAGR of 15.31% and free cash flow CAGR of 17.93% highlight its ability to generate consistent growth and profitability. With a net profit margin of 27.29% and a return on invested capital of 12.10%, Veeva demonstrates solid operational efficiency, making it a compelling player in the market despite recent price volatility. Investors will be keen to see if the stock can regain momentum and leverage its strong fundamentals to drive future growth.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.